A recent analysis of relapsed or refractory multiple Myeloma Clinical Trials concluded that combination and triple regimens are effective first-line treatment strategies. Xian-Wu Luo and a group of fellow Chinese researchers from Wuhan University performed an updated network meta-analysis because of the complex biological makeup of myeloma. They studied results from 24 clinical trials to [...]